YOLFTbeta
Tonghua Dongbao Pharmaceutical Co Ltd

Tonghua Dongbao Pharmaceutical Co Ltd

600867 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

7.60CNY-0.12 (-1.55%)

Price History

Full chart

Market Stats

Previous Close7.72
Open7.72
Day Range7.58 – 7.75
52-Week Range7.16 – 10.67
Volume15.84M
Market Cap15.39B
P/E (TTM)11.91
Forward P/E24.81
EPS0.66
Dividend Yield3.82%
Beta0.14
50-Day Avg8.11
200-Day Avg8.56

About

Tonghua Dongbao Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of biological products, traditional Chinese medicines, chemical medicines, and other drugs in China and internationally. The company offers liraglutide injections; insulin glargine injections; insulin aspart injections; human insulin injections; isophane protamine human insulin injections; mixed protamine human insulin injections; suganning capsules; pediatric paracetamol and artificial cow-bezoar and chlorphenamine maleate granules; zhennaoning capsules; compound methionine and choline bitartrate tablets; and compound kushen changyankang tablets. It also provides insulin pens and pen needles; and the Chronic Disease Management Platform, which is a diabetes management platform for drug treatment, blood glucose monitoring, and patient education. In addition, the company offers oral anti-diabetic hypoglycemic drugs, such as sitagliptin phosphate, sitagliptin phosphate/metformin hydrochloride, repaglinide, and engagliflozin tablets. Further, it engages in the manufacture, sale, and servicing of plastic building materials and products; technology development of biological products and natural medicines; leasing of workshops; real estate development and sales; second-hand housing transactions; provision of biopharmaceuticals; medical research and experimental development; pharmaceutical retail and wholesale; technical services, technology development, and technical consulting; operation of medical devices and food products; import and export of goods and technologies; internet sales; and health and consulting services. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is headquartered in Tonghua, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Jiahong Li
  • Employees3.35K
  • HeadquartersDongbao New Village, Tonghua, China, 134123, China
  • Websitehttps://thdb.com

Leadership

  • Mr. Jiahong LiChairman, President & Secretary · b. 1988
  • Mr. Guodong ZhangDeputy GM & Director · b. 1976
  • Mr. Wenhai ZhangVP & Director · b. 1974

Financials

Income Statement

Currency: CNY1994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue131.95M212.20M223.76M205.39M218.90M219.72M199.08M205.90M280.56M298.70M307.84M329.68M401.62M469.97M551.04M573.85M637.80M779.75M991.53M1.20B1.45B1.67B2.04B2.55B2.69B2.78B2.89B3.27B2.78B3.08B2.01B2.95B
Growth (%)-+60.81%+5.45%-8.21%+6.58%+0.37%-9.39%+3.43%+36.26%+6.47%+3.06%+7.09%+21.82%+17.02%+17.25%+4.14%+11.14%+22.26%+27.16%+21.45%+20.52%+15.02%+22.23%+24.75%+5.80%+3.13%+4.14%+12.99%-14.98%+10.69%-34.66%+46.66%
Cost of Revenue27.72M49.49M62.77M57.30M59.74M79.78M103.26M116.80M138.13M151.13M168.49M192.29M217.66M242.16M262.15M245.18M243.45M295.40M357.88M387.67M454.60M421.22M499.04M652.55M749.47M727.15M582.86M586.99M628.13M621.05M547.46M874.50M
Gross Profit103.93M162.71M160.99M148.09M159.17M139.94M95.81M89.10M142.43M147.57M139.35M137.39M182.72M227.81M288.89M328.67M394.35M484.35M633.65M816.57M996.74M1.25B1.54B1.89B1.94B2.05B2.31B2.68B2.15B2.45B1.46B2.07B
Gross Margin78.77%76.68%71.95%72.10%72.71%63.69%48.13%43.27%50.77%49.40%45.27%41.67%45.50%48.47%52.43%57.27%61.83%62.12%63.91%67.81%68.68%74.77%75.54%74.36%72.17%73.82%79.85%82.04%77.39%79.81%72.76%70.33%
Operating Expense31.88M59.32M42.90M42.77M53.46M55.44M42.58M77.33M89.85M101.98M173.55M115.08M124.07M185.74M208.83M276.00M203.98M453.17M578.70M610.00M669.31M678.88M802.54M906.61M950.47M1.08B1.13B1.13B321.43M1.09B1.29B1.47B
Operating Income72.06M103.39M118.09M105.31M105.70M84.50M53.23M11.77M52.58M45.59M-34.20M22.31M58.65M42.08M80.06M52.68M190.37M31.18M54.95M206.58M327.43M569.21M738.82M986.17M992.98M967.85M1.18B1.55B1.83B1.37B168.18M602.84M
Operating Margin54.61%48.72%52.78%51.28%48.29%38.46%26.74%5.72%18.74%15.26%-11.11%6.77%14.60%8.95%14.53%9.18%29.85%4.00%5.54%17.15%22.56%34.10%36.21%38.74%36.87%34.85%40.82%47.41%65.82%44.39%8.37%20.45%
EBITDA73.24M100.77M113.49M97.47M105.90M100.64M45.98M39.05M92.17M98.01M-4.68M96.97M102.71M156.04M138.33M201.63M324.92M550.14M188.49M338.22M464.21M720.06M963.89M1.16B1.16B1.13B1.27B1.68B1.98B1.56B58.09M1.77B
EBITDA Margin55.50%47.49%50.72%47.45%48.38%45.80%23.10%18.97%32.85%32.81%-1.52%29.41%25.57%33.20%25.10%35.14%50.94%70.55%19.01%28.09%31.99%43.13%47.24%45.38%43.17%40.52%43.99%51.36%71.31%50.69%2.89%60.06%
Net Income48.40M68.08M81.53M90.63M87.59M67.61M3.54M4.19M40.02M36.13M-78.25M16.20M12.06M77.43M46.82M73.72M178.37M363.98M62.71M183.91M279.78M492.96M640.92M836.55M838.61M811.21M929.92M1.31B1.58B1.17B-42.72M1.22B
Net Income Margin36.68%32.08%36.44%44.13%40.01%30.77%1.78%2.03%14.27%12.10%-25.42%4.91%3.00%16.48%8.50%12.85%27.97%46.68%6.32%15.27%19.28%29.53%31.41%32.87%31.14%29.21%32.15%40.03%56.93%37.97%-2.13%41.36%
R&D------------------47.75M62.42M50.93M80.38M65.90M96.79M97.65M78.04M106.93M166.86M146.71M74.86M102.33M167.12M
R&D as % of Total Revenue------------------4.82%5.18%3.51%4.81%3.23%3.80%3.63%2.81%3.70%5.11%5.28%2.43%5.09%5.67%
Interest Expense1.49M-----331.04K286.17K712.78K5.96M17.36M16.20M16.04M19.30M23.72M32.23M22.54M16.58M13.82M18.16M27.64M18.69M44.60M15.64M13.01M20.11M9.73M225.75K488.78K7.21M14.84M21.81M
Interest Expense % of Total Revenue1.13%-----0.17%0.14%0.25%2.00%5.64%4.91%3.99%4.11%4.30%5.62%3.53%2.13%1.39%1.51%1.90%1.12%2.19%0.61%0.48%0.72%0.34%0.01%0.02%0.23%0.74%0.74%

Balance Sheet

Currency: CNY1994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets266.52M327.48M495.92M875.03M1.18B1.50B1.47B1.46B1.57B1.80B1.81B1.88B1.97B2.27B2.17B2.25B2.19B2.38B2.38B2.69B2.96B3.79B4.68B4.75B5.46B5.35B5.80B6.52B6.75B7.77B7.38B7.91B
Total Liabilities23.54M73.88M51.55M64.70M249.82M92.79M44.10M77.96M205.52M393.95M480.12M544.23M691.13M734.97M737.66M624.75M453.75M299.37M388.92M678.23M795.72M1.31B729.76M215.30M729.06M341.10M243.80M299.87M200.74M555.08M978.08M798.84M
Total Equity242.98M253.60M444.36M810.32M902.93M1.37B1.42B1.37B1.32B1.36B1.28B1.30B1.23B1.49B1.39B1.59B1.70B2.05B1.96B1.99B2.14B2.46B3.94B4.53B4.72B5.00B5.55B6.21B6.54B7.21B6.38B7.10B
Cash-34.55M17.10M161.22M132.64M54.10M9.84M6.09M19.04M4.13M14.30M28.34M8.93M9.50M18.65M46.70M62.78M243.97M124.60M216.06M201.88M212.21M235.63M336.44M355.98M368.01M593.38M865.04M788.06M1.10B586.60M1.43B
Total Debt--18.85M30.28M38.00M60.23M3.40M3.20M52.70M298.70M371.00M386.05M521.78M594.13M591.28M492.08M330.58M215.00M317.75M539.35M608.00M1.12B490.00M5.27M450.00M125.00M2.65M2.65M2.65M150.00M696.64M-
Net Debt--34.55M1.75M-130.94M-94.64M6.14M-6.44M-2.89M33.66M294.57M356.70M357.71M512.85M584.63M572.63M445.38M267.80M-28.97M193.15M323.29M406.12M910.59M254.37M-331.17M94.02M-243.01M-590.73M-862.39M-785.41M-954.20M110.04M-

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-216.98M-95.09M29.12M117.73M31.99M45.51M13.17M92.23M158.00M120.94M92.31M166.20M160.40M-55.07M194.32M221.06M205.89M294.58M725.76M961.19M876.94M1.15B1.19B1.13B863.09M861.52M459.74M689.23M
Investing Cash Flow-41.06M-242.93M-53.47M-88.66M-98.40M-219.76M-55.95M-119.37M-296.58M-173.55M-56.67M-7.71M35.71M367.43M-244.86M-168.35M-106.04M-578.42M-837.86M-106.49M-749.71M-152.50M-616.61M34.06M343.99M-321.99M-568.93M-
Financing Cash Flow228.58M259.47M-17.94M-32.94M79.45M159.35M52.95M41.18M119.17M53.18M-26.50M-130.43M-180.04M-125.41M-67.83M39.04M-114.03M293.91M135.53M-758.19M-207.69M-954.20M-480.79M-695.60M-1.28B-223.95M-408.76M-
Capital Expenditure16.50M240.99M52.46M88.69M89.41M57.90M49.08M119.38M286.90M258.34M56.67M79.07M72.66M88.83M241.83M190.36M106.08M400.09M411.53M185.50M773.07M293.13M479.59M600.75M491.63M348.13M568.73M517.69M
Free Cash Flow-233.48M-336.08M-23.34M29.04M-57.42M-12.39M-35.91M-27.15M-128.90M-137.39M35.65M87.13M87.74M-143.90M-47.51M30.70M99.81M-105.51M314.24M775.69M103.87M859.04M712.69M533.80M371.47M513.40M-108.99M171.53M
Dividends Paid6.89M4.37M1.10M32.74M1.50M86.65M19.35M18.19M16.04M19.17M23.65M32.23M22.54M16.58M169.88M181.25M222.62M247.13M271.77M299.87M355.71M406.80M403.58M425.04M1.10B495.93M495.43M505.28M
FCF to OCF107.60%353.44%-80.13%24.66%-179.46%-27.23%-272.78%-29.44%-81.58%-113.60%38.61%52.42%54.70%261.30%-24.45%13.89%48.48%-35.82%43.30%80.70%11.84%74.56%59.78%47.05%43.04%59.59%-23.71%24.89%
Dividend Paid to FCF-2.95%-1.30%-4.73%112.74%-2.61%-699.34%-53.87%-66.98%-12.44%-13.95%66.35%36.99%25.69%-11.52%-357.54%590.44%223.05%-234.22%86.48%38.66%342.47%47.35%56.63%79.62%294.99%96.60%-454.59%294.57%

Earnings

Report DateMar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Aug 12, 2009Oct 28, 2009Mar 3, 2010Apr 14, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Oct 24, 2013Feb 26, 2014Apr 16, 2014Aug 28, 2014Oct 22, 2014Feb 25, 2015Apr 21, 2015Jul 20, 2015Oct 26, 2015Mar 2, 2016Apr 27, 2016Aug 19, 2016Oct 25, 2016Dec 31, 2016Apr 11, 2017Aug 7, 2017Oct 25, 2017Dec 31, 2017Apr 26, 2018Aug 14, 2018Oct 24, 2018Dec 31, 2018Apr 16, 2019Aug 12, 2019Oct 22, 2019Apr 14, 2020Aug 19, 2020Oct 28, 2020Jan 14, 2021Apr 26, 2021Aug 24, 2021Oct 27, 2021Jan 24, 2022Apr 18, 2022Aug 30, 2022Oct 30, 2022Feb 6, 2023Apr 26, 2023Aug 21, 2023Oct 30, 2023Jan 29, 2024Apr 26, 2024Aug 30, 2024Oct 24, 2024Apr 29, 2025Aug 25, 2025Oct 27, 2025Dec 31, 2025Apr 19, 2026Aug 24, 2026
EPS Estimate---------0.010.02-0.04-------------0.05-0.050.040.05-0.040.040.04-0.080.070.090.090.060.080.110.080.120.120.15-0.120.130.130.110.130.120.090.140.140.130.070.070.060.100.110.120.120.120.110.160.130.090.060.060.100.040.040.06
EPS Actual0.010.020.000.010.010.010.01-0.010.010.020.02-0.00-0.010.020.020.030.020.010.18-0.020.020.020.03-0.040.030.030.04-0.000.040.030.040.030.060.050.060.050.080.060.090.080.070.100.110.090.130.130.060.070.080.130.080.060.130.100.090.170.160.190.120.120.180.110.100.130.110.140.210.11-0.230.090.060.050.500.010.010.09
Surprise---------100.00%0.00%--125.00%--------------20.00%--20.00%-25.00%-20.00%-50.00%25.00%50.00%-0.00%-14.29%0.00%-11.11%16.67%25.00%0.00%12.50%8.33%8.33%-60.00%--33.33%0.00%-38.46%-45.45%0.00%-16.67%0.00%21.43%14.29%46.15%71.43%71.43%200.00%10.00%-9.09%8.33%-8.33%16.67%90.91%-31.25%-276.92%0.00%0.00%-16.67%400.00%-75.00%-75.00%50.00%
Timing---------Pre-marketPre-market-After-hours-------------After-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursPre-market-After-hoursPre-marketAfter-hours-Pre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hours-Pre-marketAfter-hours

Key Statistics & Ratios

Market Cap15.39B
Enterprise Value14.67B
Trailing P/E11.91
Forward P/E24.81
Price / Sales4.96
Price / Book2.25
EPS0.66
Book Value3.74
Revenue (TTM)3.10B
Gross Profit (TTM)2.19B
EBITDA966.18M
Profit Margin41.88%
Operating Margin19.76%
Return on Equity19.47%
Return on Assets5.56%
Shares Outstanding1.96B
Shares Float981.00M
Beta0.14
Dividend Yield3.82%
Dividend Rate0.30
Payout Ratio45.45%

Dividends

20231×
0.25Jun 9, 2023
20222×
0.25Oct 28, 20220.30Jun 8, 2022
20211×
0.21May 31, 2021
20201×
0.20May 25, 2020
20191×
0.20May 23, 2019
20181×
0.20May 25, 2018
20171×
0.17Jun 6, 2017
20161×
0.14Jun 2, 2016
20151×
0.12May 18, 2015
20141×
0.11Apr 22, 2014
20131×
0.10May 24, 2013
20121×
0.08Jun 14, 2012
20061×
0.29Jun 6, 2006
20031×
0.04Jul 8, 2003
20011×
0.02Jun 25, 2001
19961×
0.04Jul 19, 1996

Stock Splits

  • May 25, 20186:5
  • Jun 6, 20176:5
  • Jun 2, 20166:5
  • May 18, 201511:10
  • Apr 22, 201411:10
  • May 24, 20136:5
  • Jun 8, 201127:20
  • Jun 11, 20106:5
  • Jun 17, 200913:10
  • Jul 2, 19996:5
  • Dec 18, 19981053:950
  • Jul 4, 1997882:815
  • May 8, 199799283:66189